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Abstract 
Study question: What are the maternal risk factors for hyperemesis gravidarum 
(HG) hospital admission, readmission and reoccurrence in a following pregnancy? 
Summary answer: Young age, less socioeconomically deprived status, nulliparity, 
Asian or Black ethnicity, female fetus, multiple pregnancy, history of HG in a 
previous pregnancy, thyroid and parathyroid dysfunction, hypercholesterolemia and 
type 1 diabetes are all risk factors for HG. 
What is known already: Women with Black or Asian ethnicity, of young age, 
carrying multiple babies or singleton females, with type 1 diabetes or with a history of 
HG were previously reported to be at higher risk of developing HG; however most 
evidence is from small studies. Little is known about associations with other 
comorbidities and there is controversy over other risk factors such as parity. 
Estimates of HG prevalence vary and there is little understanding of the risks of HG 
readmission in a current pregnancy and reoccurrence rates in subsequent 
pregnancies, all of which are needed for planning measures to reduce onset or 
worsening of the condition.  
Study design, size, duration: We performed a population-based cohort study of 
pregnancies ending in live births and stillbirths using prospectively recorded 
secondary care records (Hospital Episode Statistics) from England. We analysed 
those computerized and anonymized clinical records from over 5.3 million women 
who had one or more pregnancies between 1997 and 2012. 
Participants/materials, setting, methods: We obtained 8,215,538 pregnancies 
from 5,329,101 women of reproductive age, with a total of 186,800 HG admissions 
occurring during 121,885 pregnancies. Multivariate logistic regression with 
generalised estimating equations was employed to estimate odds ratios (aOR) to 
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assess sociodemographic, pregnancy and comorbidity risk factors for HG onset, HG 
readmission within a pregnancy and reoccurrence in a subsequent pregnancy.  
Main results and the role of chance: Being younger, from a less 
socioeconomically deprived status, of Asian or Black ethnicity, carrying a female 
fetus or having a multiple pregnancy all significantly increased HG and readmission 
risk but only ethnicity increased reoccurrence. Comorbidities most strongly 
associated with HG were parathyroid dysfunction (aOR=3.83, 95% confidence 
interval 2.28 to 6.44), hypercholesterolemia (aOR=2.54, 1.88 to 3.44), type 1 
diabetes (aOR=1.95, 1.82 to 2.09), and thyroid dysfunction (aOR=1.85, 1.74 to 1.96). 
History of HG was the strongest independent risk factor (aOR=4.74, 4.46 to 5.05). 
Women with higher parity had a lower risk of HG compared to nulliparous women 
(aOR=0.90, 0.89 to 0.91), which was not explained by women with HG curtailing 
further pregnancies. 
Limitations, reasons for caution: Although this represents the largest population-
based study worldwide on the topic, the results could have been biased by residual 
and unmeasured confounding considering that some potential important risk factors 
such as smoking, BMI or prenatal care could not be measured with these data. 
Underestimation of non-routinely screened comorbidities such as 
hypercholesterolemia or thyroid dysfunction could also be a cause of selection bias. 
Wider implications of the findings: The estimated prevalence of 1.5% from our 
study was similar to the average prevalence reported in the literature and the 
representativeness of our data has been validated by comparison to national 
statistics. Also the prevalence of comorbidities was mostly similar to other studies 
estimating these in the UK and other developed countries. Women with Black or 
Asian ethnicity, of young age, carrying multiple babies or singleton females, with type 
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1 diabetes or with history of HG were confirmed to be at higher risk of HG with an 
unprecedented higher statistical power. We showed for the first time that 
socioeconomic status interacts with maternal age, that hypercholesterolemia is a 
potential risk factor for HG and that carrying multiple females increases risk of 
hyperemesis compared with multiple males. We also provided robust evidence for 
the association of parity with HG. Earlier recognition and management of symptoms 
via gynaecology day-case units or general practitioner services can inform 
prevention and control of consequent hospital admissions. 
Study funding/competing interest(s): The work was founded by the Rosetrees 
Trust and the Stoneygate Trust. The funders had no role in study design, data 
collection and analysis, decision to publish, or preparation of the manuscript. CNP 
reports personal fees from Sanofi Aventis, Warner Chilcott, Leo Pharma, UCB and 
Falk, outside the submitted work and she is one of the co-developers of the RCOG 
Green Top Guideline on HG; all other authors did not report any potential conflicts of 
interest. 
Trial registration number: Not applicable 
 
Keywords: hyperemesis gravidarum, severe nausea and vomiting in pregnancy, 
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Introduction 
Nausea and vomiting in pregnancy (NVP) is a very common symptom that affects 
50-90% of pregnant women and at least a third need clinical intervention (Jarvis and 
Nelson-Piercy, 2011). The most severe form of NVP, requiring medical treatment, is 
hyperemesis gravidarum (HG) which affects up to 2% of pregnant women 
(Poursharif et al., 2007). HG may lead to important maternal conditions such as 
dehydration, venous thrombosis (Virkus et al., 2014) and depression (McCarthy et al., 
2011) and offspring morbidities such as fetal growth restriction and 
neurodevelopmental delay (Fejzo et al., 2015). Considering these associated risks 
and the prevalence of HG, which is similar to that of diabetes in pregnancy, it 
potentially contributes to a significant proportion of currently under-recognised 
maternal and child morbidity.  
The aetiology of HG has been studied but the causes remain unknown and it is 
extremely difficult to predict in which women clinically important NVP will develop 
and reoccur in subsequent pregnancies. Different theories suggest that hormonal 
dysfunction (Verberg et al., 2005), multiple pregnancy (Fell et al., 2006; Roseboom 
et al., 2011) and a genetic predisposition (Zhang et al., 2011) are all associated risk 
factors for HG. However most evidence is based on small studies and includes a 
varied spectrum of severity. In-patient hospital admissions characterised by 
excessive NVP in 2011 were just under 35,000 for England alone, according to 
national maternity statistics (Trevelyan Square, 2012). Controversial results have 
been shown to quantify the extent to which women in the general population will 
develop HG in first and subsequent pregnancies based on some of their baseline 
risk factors (Vikanes A, Grjibovski AM, Vangen S and Magnus P., 2008; Y. Fan and 
H. Jacobsen, 2010). 
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We assessed over 8 million pregnancies, from hospital records that cover all of 
England, to quantify the burden of HG and identify important risk factors for HG 
admission, readmission and reoccurrence in subsequent pregnancies. 
 
Materials and Methods 
 
Study population 
The Hospital Episodes Statistics (HES) data contain information on all patients’ 
hospital admissions and outpatient appointments recorded by English secondary 
care settings within the National Health Service (NHS) hospitals and independent 
sectors commissioned by the NHS (Health and Social Care Information Centre, 
2010). Details of the episode of care include diagnoses defined using International 
Classification of Diseases version 10 (ICD-10) codes (World Health Organization, 
2010) and procedures defined using Office of Population Censuses and Surveys 
Classification of Interventions and Procedures (OPCS-4) codes (NHS Connecting for 
Health, 2012). In-patient admissions data have been collected since April 1997 and a 
subset of these data, known as the HES maternity dataset contains details on all 
delivery admissions in mothers’ records and on all birth admissions for newborns 
born alive or stillborn. This dataset has been previously validated for perinatal 
studies (Bragg et al., 2010). We created a cohort of all completed pregnancies by 
extracting every delivery recorded in the HES maternity dataset where a pregnancy 
started after 6th April 1997 and the delivery was before 5th April 2012. 
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Hyperemesis gravidarum definition and severity 
All antenatal hospital admissions with an ICD-10 code for HG in the primary 
diagnosis field were extracted from HES. A pregnancy was considered to be affected 
by HG if at least one admission with primary diagnosis for HG was recorded during 
the gestational period excluding the delivery admission. There is no standard 
measure to assess HG severity and HES does not provide information on 
intravenous fluids and drug treatments given during admission, so we assessed 
women’s total number of admissions for HG, their total length of hospital stay (in 
days) and the distribution of admission across pregnancy trimesters.  
 
Risk factors 
Risk factors were primarily pre-specified based on associations with NVP or HG 
previously-reported (Fell et al., 2006; Roseboom et al., 2011) and their availability in 
HES. Demographic factors extracted directly from patients’ admission records were 
maternal age at the pregnancy outcome, ethnicity and socioeconomic deprivation as 
measured by the Index of Multiple Deprivation (IMD 2010) in quintiles. The IMD 
overall ranking is made by combining seven IMD Domain scores (such as income, 
employment, disability, education) for Lower Layer Super Output Areas (LSOAs) 
(Department for Communities and Local Government and The Rt Hon Eric Pickles, 
2010)  which cover approximately 600 households. Hospital admission data were 
used to assess whether women had a history of HG during a previous pregnancy 
and the maternal comorbidities, diabetes (pre-existing, gestational and unspecified), 
hypertension (pre-existing and gestational), hypercholesterolemia, anaemia, thyroid 
dysfunction and parathyroid dysfunction. Although the association between 
hypercholesterolemia and NVP or HG has not been studied previously, it is widely 
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considered as an important complication of pregnancy and was also considered as a 
suitable proxy for body mass index (BMI), data on which were not available. As the 
dates of diagnoses are not reported in HES data, we looked at all diagnoses 
recorded in any admission during the given pregnancy. 
The sex of the baby, birth plurality (singleton, twins or other multiple delivery) and 
parity were obtained from the delivery record in HES maternity data. As parity was 
incomplete (30% missing) in the delivery record, we additionally used any previously 
recorded incident deliveries in HES and any diagnostic codes with information on 
parity. This approach reflects different methods in other work previously published 
and is in agreement with their final results.(Bragg et al., 2010; Cromwell et al., 2014; 
Sandall et al., 2014) Such methodology to estimate parity using a look-back 
technique has been shown to provide accurate estimations of multiparous women 
but can compromise accuracy of nulliparity (Cromwell et al., 2014). For this reason, 
we performed a sensitivity analysis restricting the population to women who were 
from under 20 years of age during the study period to ensure that all their 
pregnancies were included in the dataset and that the nulliparous rate was as 
accurate as possible. 
 
Statistical analysis 
We calculated the prevalence of HG as a proportion of all pregnancies and assessed 
variation across all risk factors. We performed logistic regression using a generalised 
estimating equation (GEE) to account for potential clustering effects from women 
who had more than one pregnancy during the study period (Hanley et al., 2003). We 
estimated odds ratios (OR) and 95% confidence intervals (CI) for HG associated with 
each risk factor, adjusted for maternal age, ethnicity, socioeconomic quintile, parity, 
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sex of the baby, birth plurality, history of HG in a previous pregnancy, maternal 
comorbidities, year of delivery, and region of secondary care setting, unless they 
were the risk factor of interest. Results were presented with 95% confidence 
intervals to facilitate comparison with prior studies, however in view of the large 
number of factors (and categorisations thereof) investigated, there was a risk of 
identifying spurious associations. We therefore used the Benjamini-Hochberg 
procedure (Benjamini and Hochberg, 1995) to impose a maximum overall false 
discovery rate (FDR) of 1% for each major outcome (HG, HG readmission and HG 
recurrence) modelled. Associations where the confidence interval implied 
significance, but which were rejected under the FDR criterion are highlighted in the 
results and should be interpreted cautiously. Missing values for any variable were 
coded and analysed as a separate category. 
We described the burden of HG admissions according to the number and length of 
admissions by trimester (trimester 1 – last menstrual period (LMP) to 13 completed 
weeks; trimester 2 – start of 14th week to 28 completed weeks; trimester 3 – start of 
29th week to delivery) and gestational week (from LMP). We calculated rate of 
readmission over all pregnancies with HG. We estimated risk of readmission and 
reoccurrence and assessed which risk factors were associated with each using 
multivariate logistic regression analysis with a GEE model. For readmission, we 
compared women with at least one HG readmission to women with no admissions 
for HG to compare the potentially severe HG cases to the same reference group as 
the mild HG cases. We assessed reoccurrence of HG amongst women who had HG 
in their first recorded pregnancy by comparing women with HG in the subsequent 
pregnancy to women without reoccurrence. We looked for evidence that deprivation 
might modify the effect of age on each outcome by adding an interaction term 
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between age group and IMD quintile to the adjusted model. Where the inclusion of 
this interaction improved the model fit (assessed using Wald tests in the clustered 
HG and HG readmission outcome models, and likelihood ratio tests in the non-
clustered HG reoccurrence model), we used a cell means model to obtain IMD 
quintile-specific estimates of the effects of age. All statistical analyses were 
conducted with Stata version 14. 
 
Ethical Approval 
All data are anonymised, such that individual patients as well as the name and 
specific location of residence cannot be identified by researchers.  Ethical approval 
for this study was obtained from The Health & Social Care Information Centre (DSA 
Reference: NIC-383714-V7G7Q). 
 
Results 
 
There were 8,215,538 pregnancies among 5,329,101 women between 1997 and 
2012 of which 0.54% resulted in stillbirths and 1.6% were multiple deliveries. The 
prevalence of HG in pregnancy was 1.48% with a total of 121,885 pregnancies being 
affected by at least one primary admission for HG over the study period. Prevalence 
of admission for HG in pregnancy increased from 1.03% of pregnancies whose 
delivery occurred in 1998 to 1.75% of pregnancies whose delivery occurred in 2011 
and this increase was statistically significant after adjusting for changes in the 
population’s maternal characteristics over time (aOR=1.48, 95%CI=1.43 to 1.53 in 
2011 compared to 1998). 
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Risk factors for hyperemesis gravidarum hospital admissions 
Figures for the crude prevalence of HG by maternal characteristics (Table 1) showed 
that women under the age of 30, with Asian or Black ethnicity and those living in 
more socioeconomically deprived areas were more likely to be admitted for HG. 
Multiple pregnancies and female fetal sex were also associated with a significantly 
increased risk of HG as was history of HG in a previous pregnancy and pre-existing 
and gestationally developing comorbidities. Adjusted odds ratios for HG in Table 1 
show the highest risk of HG in women with Asian and Black ethnicity compared to 
white ethnicity (aOR=1.82, 95%CI=1.79 to 1.86 and aOR=2.14, 95%CI=2.09 to 2.19 
respectively), whereas Chinese women had lower odds of being affected by HG 
(aOR=0.58, 95%CI=0.52 to 0.66). Female fetal sex and multiple pregnancies 
interacted to increase HG risk such that singleton females conferred higher odds 
compared to male singletons (aOR=1.23, 95%CI=1.22 to 1.25) and multiple 
pregnancies with all female children conferred higher odds of HG (aOR=2.41, 95%CI 
2.24 to 2.59) compared to all male children (aOR=2.02, 95%CI 1.86 to 2.18). A 
history of HG in previous pregnancies was the greatest risk factor for HG in the 
current pregnancy after adjusting for all other maternal characteristics (aOR=4.74, 
95%CI=4.46 to 5.05). Parathyroid dysfunction, hypercholesterolemia and type 1 
diabetes were the comorbidities associated with the highest risk of HG with aORs of 
3.83 (95%CI=2.28 to 6.44), 2.54 (95%CI=1.88 to 3.44) and 1.95 (95%CI=1.82 to 
2.09) respectively, followed by thyroid dysfunction and anaemia. Parous women had 
a lower risk of HG compared to nulliparous women (aOR=0.90, 95%CI=0.89 to 0.91) 
and this did not appear to be explained by women with HG having fewer subsequent 
pregnancies; 44% of them had a second pregnancy compared with 43% of women 
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without HG. Risk factors generally showed the same patterns of association in 
nulliparous and parous women (Supp. Table 1, Supp. Figure 1). Restricting the 
population to pregnancies where women were from under 20 years of age during the 
study period (3,640,012 pregnancies) showed similar patterns of HG risk in both 
nulliparous and parous women as found for the whole population.  
 
Hospital readmission for hyperemesis gravidarum 
Risk factors associated with readmission for HG (Table 1) showed similar patterns to 
those for HG admission overall but generally with stronger association especially for 
history of HG in previous pregnancies, thyroid and parathyroid dysfunctions, 
hypercholesterolemia, birth plurality and Asian or Black ethnicity.  
 
Maternal age and socio-economic status 
In the adjusted analysis we still observed an increased risk of HG and HG 
readmission among women under 30 years of age compared with those aged 30-34, 
and a decreased risk in the older age groups up to age 45 (Figure 1). However, in 
contrast with the figures for the crude prevalence of HG, the increased risks were 
most pronounced among those in the least deprived socioeconomic groups. The 
highest risk group overall was those in the least deprived group aged 20-24 years 
(aOR=1.85, 95%CI=1.76 to 1.96 for HG and aOR=1.71, 95%CI=1.55 to 1.91 for HG 
readmission). The lowest risk of HG was in women aged 45 or more years from the 
most deprived group (aOR=0.61, 95%CI=0.43 to 0.87 for HG and aOR=0.51, 
95%CI=0.24 to 1.07 for HG readmission). However the risk of HG in those women 
was nonsignificant according to the 1% FDR criterion and should therefore be 
interpreted cautiously. 
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Reoccurrence of hyperemesis gravidarum in a following pregnancy 
In the overall population, women affected by HG in one pregnancy and who had a 
subsequent pregnancy were 33,214 of whom 8,674 had HG in the following 
pregnancy, accounting for 26% of the risk of HG reoccurrence in a subsequent 
pregnancy (Table 2); only Asian or Black ethnicity and thyroid dysfunction increased 
the risk of HG reoccurrence, although the result for thyroid dysfunction was 
nonsignificant according to the 1% FDR criterion and should therefore be interpreted 
cautiously. 
 
Burden of hyperemesis gravidarum in England 
A total of 186,800 HG admissions occurred during 121,885 pregnancies, the 
characteristics of which are shown in Table 3. The readmission rate was 28% and 
within pregnancies with HG, 72% had only one admission, 17% experienced two 
admissions, whereas 11% had three or more admissions. The vast majority of 
pregnancies had admissions only in the first trimester (71% of pregnancies with HG), 
whereas 25% had admissions up to the second trimester and 4% up to the third 
trimester. Only 10% of pregnancies with admissions for HG were managed as day 
cases whereas 33% had more than four days of in-patient hospital stay during the 
pregnancy. HG admissions peaked at eight weeks’ gestation (Figure 2) with a 
median length of hospital stay during the first 18 weeks’ gestation of three days 
(interquartile range(IQR) 2-4) which then decreased to two days (IQR 1-3 days). Of 
the total admissions, 74% were through an emergency route, 24% were through a 
maternity ward and only 1% were elective. 
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Discussion 
 
Main findings 
With over 8 million pregnancies, we conducted one of the largest studies 
internationally to assess the occurrence and reoccurrence of HG and the risk factors 
for HG hospital admission. Admission for HG has increased over time, occurring in 
1.75% of pregnancies where women delivered in 2011 and with a total of 17,629 
admissions in 2010 (only for pregnancies ending in live births and stillbirths). Over 28% 
of women with HG had readmissions within the same pregnancy and the 
reoccurrence rate in following pregnancies was 26%. This represents a substantial 
burden on hospitals, which could be reduced or potentially prevented with earlier 
recognition and management of symptoms in the first trimester via gynaecology day 
case, midwifery or general practitioner services. We also identified that younger age, 
less socioeconomically deprived status, Asian or Black ethnicity, a female fetus, 
multiple pregnancy, nulliparity and several comorbidities are all independent risk 
factors for HG; these factors could assist in earlier recognition. 
 
Strengths and limitations 
We used a rigorous approach in including only records of admission specifying a 
primary diagnosis of HG, thus excluding a proportion of admissions (3.7%) where 
HG was reported as secondary diagnosis. Nevertheless, the estimated prevalence of 
1.5% from our study was similar to or higher than the average prevalence reported in 
the literature (Verberg et al., 2005; Vikanes A, Grjibovski AM, Vangen S and Magnus 
P., 2008; Roseboom et al., 2011; Bolin et al., 2013; Virkus et al., 2014).  HG 
prevalence showed a constant increase over time possibly due to either an 
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improvement of the coding specificity for HG versus NVP or an increased number of 
cases presenting to hospital for care and support. 
HES data allowed collection of information on the relevant maternal risk factors 
assessed in this analysis with a fairly low rate of missing values for socio-economic 
status (0.7%), sex of the baby (3.9%), birth plurality (0.4%) and ethnicity (13.4%). 
The completeness of birth information in maternity HES has been improving over 
time (Murray et al., 2012) and the representativeness of our data has been validated 
by comparison to national statistics (ONS, 2010) and other datasets extracted from 
HES (Bragg et al., 2010; Sandall et al., 2014). Maternal comorbidities could have 
been underestimated, missing for instance mild cases of anaemia or diabetes 
managed in primary care or outpatient secondary care. Nevertheless the prevalence 
of comorbidities was similar to that in other studies estimating these in the UK and 
other countries, indicating that women’s delivery records capture most relevant 
comorbidities. We acknowledge that the findings may be affected by residual 
confounding and unmeasured confounding considering that some potential important 
risk factors such as smoking, BMI or prenatal care could not be measured with these 
data. We assessed severity of HG using hospital readmissions, however this may 
not fully capture severity as readmission in the current pregnancy or reoccurence in 
a following pregnancy is influenced also by other factors like primary care support, 
mental attitude and sociocultural factors (McCarthy et al., 2011).   
Comparison with previous studies 
Younger maternal age, birth plurality (Fell et al., 2006; Roseboom et al., 2011), Black 
and Asian ethnicity (Vikanes A, Grjibovski AM, Vangen S and Magnus P., 2008), 
carrying a singleton female baby (Fell et al., 2006; Roseboom et al., 2011), history of 
HG in previous pregnancies (Zhang et al., 2011) and type 1 diabetes (Fell et al., 
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2006; Roseboom et al., 2011) were all risk factors for HG, in agreement with 
previous work. Our large study power additionally enabled us to assess the 
relationship between birth plurality and fetal sex which showed a higher risk with 
multiple females compared with multiple males, which supports higher oestrogen 
levels in the development of HG (Schiff et al., 2004). Among women under 30 years 
of age, we also found a more pronounced increased risk of HG for those in the least 
deprived socioeconomic group according to the IMD score, a well validated national 
measure. These variations could be due to different possible scenarios such as 
young women from least deprived groups having lower endurance levels to 
uncomfortable symptoms or older women from most deprived groups being more 
likely to stay at home for sustaining family needs.  A Norwegian study showed that 
fewer years of education was associated with higher HG prevalence (Vikanes et al., 
2013) whereas the opposite was found in an American study (Schiff et al., 2004), 
although neither were in adjusted analyses. Whilst contrasting results from previous 
studies (Fell et al., 2006; Louik et al., 2006; Vikanes et al., 2013) and a systematic 
review (Y. Fan and H. Jacobsen, 2010) showed that the association between HG 
and parity is not yet well defined, our study showed that nulliparous women had a 
higher risk of admission for HG compared to parous women, after adjusting for 
differing maternal characteristics. This was not explained by women with HG 
curtailing further pregnancies as the proportion of women going on to have 
subsequent pregnancies was actually similar between women with and without HG 
in their first pregnancy (44% and 43% respectively). Maternal thyroid dysfunction  
and anaemia were associated with HG in our study as well as in previous studies 
(Verberg et al., 2005; Jarvis and Nelson-Piercy, 2011), however the timing of onset 
of these complications relative to HG is difficult to ascertain in these data. 
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Hypercholesterolemia had a strong association with HG and to our knowledge no 
studies have explored this so far. However this result could be affected by selection 
bias as hypercholesterolemia, as well as thyroid and parathyroid dysfunctions, is not 
routinely tested for in pregnancy in the UK and thus could have been 
underdiagnosed in many otherwise healthy women. We found no evidence of 
association with pre-existing hypertension which was shown in a previous Dutch 
study, albeit in unadjusted analyses (Roseboom et al., 2011).  
Risk for HG reoccurrence was 15% (Trogstad et al., 2005) in a Norwegian study, 
possibly affected by an underestimation of HG prevalence, and 48% in an American 
study, likely affected by selection bias (Fejzo et al., 2011). The reoccurrence risk of 
26% shown in our study was based on evidence from 33,214 women with HG in their 
initial pregnancies.  
Conclusions 
Hyperemesis gravidarum is an extremely debilitating condition that has physical, 
psychological, social and economic impact on affected women and their families. We 
have shown that it is responsible for a significant proportion of hospital admissions 
during pregnancy. However, it is still underestimated by the health professional 
community resulting in inadequate supportive care for the affected women 
(Poursharif et al., 2007; Gadsby et al., 2011). This current assessment of HG risk 
factors in England highlights those women where prediction and possible control of 
the deterioration of this condition may improve care and reduce admissions 
(McCarthy et al., 2014).  
Unanswered questions and future research 
More research is needed to understand the underlying causes of HG including the 
role of hormonal changes in pregnancy and other pre-existing comorbidities such as 
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psychiatric conditions. Which type of treatment is effective in reducing admissions 
and readmission rates and what role prophylactic antiemetic treatments can have 
are other important unanswered questions. Future studies should also assess the 
role of out-patient care in the management of HG.  
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Table 1. Risk of hyperemesis gravidarum according to maternal characteristics (N=8,215,538 
pregnancies) 
 
 
 
n % n % n % AORᵇ 95% CI AORᵇ 95% CI
Maternal age at delivery (years)
< 20 545,291 6.74 9,796 8.04 2,410 6.94
20-24 1,515,108 18.72 31,619 25.94 8,739 25.18
25-29 2,187,967 27.03 37,241 30.55 11,041 31.81
30-34 2,334,278 28.84 28,590 23.46 8,337 24.02
35-39 1,245,589 15.39 12,185 10.00 3,519 10.14
40-44 252,929 3.13 2,322 1.91 621 1.79
≥ 45 12,491 0.15 130 0.11 37 0.11
Socioeconomic quintile
1 (least deprivation) 1,305,784 16.13 13,625 11.18 3,722 10.72
2 1,328,418 16.41 15,585 12.79 4,344 12.52
3 1,461,670 18.06 19,817 16.26 5,528 15.93
4 1,728,277 21.35 27,506 22.57 7,850 22.62
5 (most deprivation) 2,216,406 27.38 44,801 36.76 13,105 37.76
missing 53,098 0.66 551 0.45 155 0.45
Ethnicity
White 5,579,842 68.94 74,376 61.02 20,111 57.95
Black and white 98,936 1.22 2,304 1.89 668 1.92 1.56 1.49-1.63 1.66 1.53-1.81
Asian 738,389 9.12 20,345 16.69 6,741 19.42 1.82 1.79-1.86 2.12 2.05-2.19
Black 384,520 4.75 11,928 9.79 3,613 10.41 2.14 2.09-2.19 2.33 2.24-2.43
Chinese 41,296 0.51 313 0.26 85 0.24 0.58 0.52-0.66 0.60 0.48-0.76
Other 168,194 2.08 2,730 2.24 810 2.33 1.22 1.17-1.27 1.37 1.27-1.48
missing 1,082,476 13.37 9,889 8.11 2,676 7.71 0.79 0.77-0.81 0.80 0.76-0.83
Birth pluralityᶜ
singleton 7,932,988 98.01 117,866 96.70 33,398 96.24
twins 121,083 1.50 3,383 2.78 1,111 3.20 2.09 2.02-2.16 2.43 2.29-2.59
triplets and more 5,613 0.07 163 0.13 62 0.18 2.33 1.99-2.72 3.17 2.46-4.09
unknown 33,969 0.42 473 0.39 133 0.38 0.97 0.89-1.07 0.95 0.79-1.14
Sex of the baby
Male 3,868,562 47.80 51,899 42.58 14,314 41.25
Female 3,814,614 47.13 62,459 51.24 18,202 52.45 1.23 1.22-1.25 1.30 1.27-1.33
not sepcified 8,663 0.11 98 0.08 30 0.09 0.91 0.75-1.12 1.00 0.69-1.45
Multiple males 26,352 0.33 657 0.54 204 0.59 2.02 1.86-2.18 2.26 1.95-2.61
Multiple mixed 34,577 0.43 965 0.79 325 0.94 2.43 2.28-2.60 2.96 2.64-3.31
Multiple females 26,027 0.32 774 0.64 264 0.76 2.41 2.24-2.59 2.98 2.63-3.38
missing 314,858 3.89 5,033 4.13 1,365 3.39 1.17 1.14-1.21 1.15 1.08-1.21
Parity ≥1 3,862,650 47.72 59,491 48.81 17,116 49.32 0.90 0.89-0.91 0.74 0.72-0.75
History of HG 32,353 0.4 11,606 9.52 5,500 15.85 4.74 4.46-5.05 19.5818.60-20.61
Diabetesᵈ
type 1 29,072 0.36 873 0.72 248 0.71 1.95 1.82-2.09 1.83 1.60-2.09
type 2 8,968 0.11 166 0.14 50 0.14 0.99 0.84-1.16 0.95 0.71-1.28
gestational 122,177 1.51 1,944 1.59 569 1.64 0.95ᵉ 0.90-0.99 0.92 0.84-1.01
unspecified 17,026 0.21 226 0.19 76 0.22 0.82 0.71-0.93 0.92 0.73-1.17
Hypertensionᵈ
pre-existing 28,940 0.36 440 0.36 120 0.35 1.07 0.97-0.18 1.01 0.83-1.22
gestational 239,952 2.96 4,068 3.34 1,292 3.72 1.17 1.13-1.21 1.32 1.24-1.40
unspecified 241,491 2.98 4,201 3.45 1,196 3.45 1.17 1.14-1.21 1.16 1.10-1.24
Anaemiaᵈ 391,268 4.83 8,822 7.24 2,800 8.07 1.34 1.31-1.37 1.44 1.38-1.50
Thyroid dysfunctionᵈ 46,619 0.58 1,313 1.08 483 1.39 1.85 1.74-1.96 2.26 2.05-2.50
Parathyroid dysfunctionᵈ 255 0.00 21 0.02 10 0.03 3.83 2.28-6.44 5.05 2.20-11.61
Hypercholesterolaemiaᵈ 1,085 0.01 52 0.04 20 0.06 2.54 1.88-3.44 3.05 1.83-5.06
ᵅOdds ratios for having one or more readmissions for HG in a pregnancy compared with no admissions, according to each risk factor
ᵈ Diagnosis recorded at any admisson during the current pregnancy
ᵉ nonsignificant at 1% FDR target (see statistical methods)
Refer to results from interaction analysis 
in Fig 1
ᶜ For this risk factor a separate model was built excluding sex of the baby from the list of confounders
Maternal and pregnancy 
characteristics
Pregnancies in women 
Risk of HG
Risk of HG 
readmissionᵅ
without HG 
N=8,093,653
with HG N=121,885
with HG readmission 
N=34,704
ᵇ Odds ratios for HG according to each risk factor adjusted for maternal age, ethnicity, socioeconimic quintile, sex of the baby, year of delivery, region of secondary care setting and all comorbidities, , unless they were the risk 
factor of interest. An interaction term between maternal age socioeconimic quintile was added to the adjusted model. Reference for parity=nulliparous
reference
reference
reference
HG=Hyperemesis gravidarum defined by at least one primary diagnosis during a pregnancy hospital admission. 95%CI= 95% confidence interval
Refer to results from interaction analysis 
in Fig 1
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Table 2. Risk of reoccurrence of hyperemesis gravidarum in a subsequent pregnancy 
according to maternal characteristics
 
n
% with 
reoccurrence
Maternal age at delivery (years)
< 20 1,072 21.88
20-24 2,885 25.75
25-29 2,774 27.47
30-34 1,571 28.35
35-39 346 25.37
40-44 25 24.04
≥ 45 ᵇ n/a
Socioeconomic quintile
1 (least deprivation) 960 28.39
2 1,083 26.44
3 1,384 26.30
4 1,940 25.95
5 (most deprivation) 3,267 25.41
missing 40 28.37
Ethnicity
White 5,122 24.73
Black and white 175 27.13 1.19 0.99-1.42
Asian 1,862 29.67 1.29 1.21-1.39
Black 1,013 29.84 1.33 1.21-1.46
Chinese 18 18.75 0.67 0.40-1.12
Other 142 22.26 0.88 0.72-1.06
missing 342 23.51 0.89 0.79-1.01
Diabetesᶜ
type 1 39 21.43 0.75 0.52-1.07
type 2 ᵇ n/a 0.38 0.11-1.29
gestational 67 22.87 0.80 0.61-1.05
unspecified 18 29.51 1.10 0.63-1.92
Hypertensionᶜ
pre-existing 27 29.35 1.19 0.76-1.88
gestational 351 27.64 1.08 0.95-1.22
unspecified 308 24.06 0.91 0.80-1.04
Anaemiaᶜ 730 28.39 1.09 0.99-1.19
Thyroid dysfunctionᶜ 79 33.91 1.45ᵈ 1.10-1.90
Parathyroid dysfunctionᶜ ᵇ n/a 1.49 0.27-8.25
Hypercholesterolaemiaᶜ ᵇ n/a 1.40 0.34-5.75
HG= Hyperemesis g ravidarum defined by at least one  primary diagnosis during a pregnancy  hospital admission
ᵇ a figure between 1 and 5
ᶜ Diagnosis recorded at any admisson during the current pregnancy
ᵈ nonsignificant at 1% FDR target (see statistical methods)
n/a= not applicable
See Fig 1
reference
ᵅ Odds ratios for HG reocurring in pregnancy compared with not reocurring, according to each risk factor adjusted for maternal age, ethnicity, 
socioeconimic quintile, year of delivery, region of secondary care setting and all comorbidities, unless they were the risk factor of interest. An 
interaction term between maternal age socioeconimic quintile was added to the adjusted model.
Maternal and pregnancy 
characteristics
Reoccurrence of HG in pregnancy 
(N=33,214 pregnancies in women with HG 
in their previous pregnancy)
Adjusted Odds Ratio for 
reocurrenceᵅ with 95% 
confidence interval
See Fig 1
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Table 3. Frequency and gestational timing of hyperemesis gravidarum admissions 
n
Number of admissions per pregnancy: 
Mean (95% confidence interval)
1.53 (1.53-1.54) 2.27 (2.26-2.29)
Number of admissions per pregnancy
1 87,181 71.53 106.12
2 20,614 16.91 25.09
3 7,131 5.85 8.68
4 3,253 2.67 3.96
> 4 3,706 3.04 4.51
Trimester of admissionsᵅ
first trimester only 85,981 70.54 104.66
up to second trimester 31,065 25.49 37.81
up to third trimester 4,839 3.97 5.89
Admission length (days) in pregnancy
1 12,919 10.60 15.73
2 28,613 23.48 34.83
3 25,786 21.16 31.39
4 14,057 11.53 17.11
> 4 40,510 33.24 49.31
Admission length (days) in first trimesterᵇ
1 69,412 56.95 84.49
2 17,323 14.21 21.09
3 5,651 4.64 6.88
4 2,330 1.91 2.84
> 4 1,744 1.43 2.12
Admission length (days) in second trimesterᵇ
1 26,516 21.75 32.28
2 3,430 2.81 4.18
3 981 0.80 1.19
4 448 0.37 0.55
> 4 452 0.37 0.55
Admission length (days) in third trimesterᵇ
1 4,391 3.60 5.34
2 330 0.27 0.40
3 76 0.06 0.09
4 22 0.02 0.03
> 4 20 0.02 0.02
HG=Hyperemesis gravidarum defined by at least one primary diagnosis during a pregnancy hospital admission
ᵇ Pregnancy may have admissions in more than one trimester so total will exceed total number of pregnancies with HG
ᵅ Pregnancies with admissions in 1st trimester only, 2nd trimester (with or without 1st trimester admissions but no 3rd trimester admissions), 3rd 
trimester admissions (with or without 1st and 2nd trimester admissions)
Pregnanices according to admission 
characteristics                 
 Percentage of 
pregnancies among 
women with HG only 
(N=121,885) 
 Per 10,000 
pregnancies 
(N=8,215,538) 
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Figure 1. Risk of hyperemesis gravidarum (HG), readmission and reoccurrence in a following 
pregnancy: IMD quintile-specific estimates of the effects of age (aOR= adjusted odds ratio, CI= 
confidence interval). 
 
¹ Results for the subgroup of women with age ≥ 45 and socio-economic status 5 are nonsignificant at 
1% FDR target (see statistical methods) 
² Results for the subgroup of women with age 35-39 and socio-economic status 1 are nonsignificant 
at 1% FDR target (see statistical methods) 
³ Results for the subgroups of women with age <20 and socio-economic status 4, age 20-24 and 
socio-economic status 1, 2 or 5, age 25-29 and socio-economic status 3, and age 35-39 and socio-
economic status 2 or 5 are nonsignificant at 1% FDR target (see statistical methods) 
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Figure 2. Admissions for hyperemesis gravidarum by gestational week (IQR=interquartile range) 
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Supplementary Figure 1: Risk of hyperemesis gravidarum in parous and nulliparous: IMD quintile-specific estimates of the effects 
of age (aOR= adjusted odds ratio, CI= confidence interval). 
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Suppl Table 1. Risks of hyperemesis gravidarum in nulliparous and parous women separately 
(N=8,215,538 pregnancies) 
 
 
Ethnicity
White
Black and white 1.50 1.41-1.60 1.54 1.45-1.63
Asian 1.91 1.87-1.96 1.59 1.55-1.63
Black 2.16 2.09-2.23 1.93 1.87-1.99
Chinese 0.57 0.49-0.66 0.65 0.55-0.77
Other 1.23 1.17-1.30 1.19 1.12-1.27
missing 0.78 0.76-0.80 0.85 0.82-0.88
Birth pluralityᵇ
singleton
twins 2.16 2.06-2.26 2.07 1.96-2.18
triplets and more 2.38 1.94-2.91 2.33 1.80-3.02
unknown 0.96 0.85-1.08 0.97 0.84-1.14
Sex of the baby
Male
Female 1.22 1.20-1.24 1.24 1.22-1.27
not sepcified 0.79 0.59-1.04 1.10 0.83-1.47
Multiple males 2.07 1.85-1.31 2.01 1.79-2.26
Multiple mixed 2.55 2.34-2.79 2.36 2.14-2.61
Multiple females 2.43 2.20-2.70 2.45 2.20-2.72
missing 1.19 1.14-1.23 1.14 1.09-1.19
Diabetesᶜ
type 1 2.16 1.96-2.38 1.72 1.56-1.91
type 2 0.94 0.71-1.25 1.03 0.84-1.25
gestational 0.96 0.89-1.04 0.93 0.88-0.99
unspecified 0.89 0.74-1.08 0.74 0.62-0.89
Hypertensionᶜ
pre-existing 1.14 0.99-1.30 1.02 0.89-1.17
gestational 1.15 1.10-1.20 1.23 1.17-1.30
unspecified 1.14 1.10-1.19 1.23 1.17-1.29
Anaemiaᶜ 1.31 1.27-1.35 1.39 1.34-1.44
Thyroid dysfunctionᶜ 2.10 1.93-2.29 1.65 1.53-1.78
Parathyroid dysfunctionᶜ 4.61 2.28-9.31 3.17 1.42-7.07
Hypercholesterolaemiaᶜ 2.71 1.74-4.21 2.56 1.70-3.85
ᶜ Diagnosis recorded at any admisson during the current pregnancy
ᵇ For this risk factor a separate model was built excluding sex of the baby from the list of confounders
Maternal and pregnancy 
characteristics
Pregnancies in 
nulliparous women 
Pregnancies in parous 
women 
N=4,293,397            N=3,922,141                
Adjusted Odds Ratiosᵅ with 95% confidence 
reference
reference
reference
HG=Hyperemesis gravidarum defined by at least one primary diagnosis during a pregnancy hospital admission
ᵅOdds ratios for HG according to each risk factor adjusted for maternal age, ethnicity, socioeconimic quintile, sex of the 
baby, year of delivery, region of secondary care setting and all comorbidities, unless they were the risk factor of interest. 
Reference for parity=nulliparous
